Comparison of predictors for terminal disease progression in simian immunodeficiency virus/simian-HIV-infected rhesus macaques. 2021

Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
Division of Immunology, Tulane National Primate Research Center, Covington, Louisiana.

CD4+ T-cell decline and increasing virus levels are considered hallmarks of HIV/AIDS pathogenesis but we previously demonstrated in rhesus macaques that tissue macrophage destruction by simian immunodeficiency virus (SIV) infection associated with increased monocyte turnover also appear to impact pathogenesis. It remains unclear, however, which factors best predict onset of terminal disease progression and survival time. The objective of this study, therefore, was to directly compare these co-variates of infection for predicting survival times in retrospective studies of SIV/simian-HIV (SHIV)-infected adult rhesus macaques. Rhesus macaques were infected with various strains of SIV/SHIV and evaluated longitudinally for monocyte turnover, CD4+ T-cell loss, plasma viral load, and SIV/SHIV strain. Correlation analyses and machine learning algorithm modeling were applied to compare relative contributions of each of the co-variates to survival time. All animals with AIDS-related clinical signs requiring euthanasia exhibited increased monocyte turnover regardless of CD4+ T-cell level, viral strain, or plasma viral load. Regression analyses and machine learning algorithms indicated a stronger correlation and contribution between increased monocyte turnover and reduced survival time than between CD4+ T-cell decline, plasma viral load, or virus strain and reduced survival time. Decision tree modeling categorized monocyte turnover of 13.2% as the initial significant threshold that best predicted decreased survival time. These results demonstrate that monocytes/macrophages significantly affect HIV/SIV pathogenesis outcomes. Monocyte turnover analyses are not currently feasible in humans, so there is a need to identify surrogate biomarkers reflecting tissue macrophage damage that predict HIV infection disease progression.

UI MeSH Term Description Entries
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
February 2015, Journal of virology,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
September 2000, Veterinary pathology,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
July 1995, Journal of virology,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
June 2007, Journal of virology,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
June 1998, Journal of neurovirology,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
February 2003, The Journal of infectious diseases,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
January 1992, Journal of clinical laboratory analysis,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
January 1992, Journal of medical primatology,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
July 2005, The Journal of infectious diseases,
Naofumi Takahashi, and Amir Ardeshir, and Gerard E Holder, and Yanhui Cai, and Chie Sugimoto, and Kazuyasu Mori, and Mariluz Araínga, and Ziyuan He, and Yayoi Fukuyo, and Woong-Ki Kim, and Elizabeth S Didier, and Marcelo J Kuroda
January 2005, Veterinary pathology,
Copied contents to your clipboard!